Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER...

14
undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2 Speaker: John MS Bartlett Slide 1 / 27 Slide 2 / 27 Page 1

Transcript of Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER...

Page 1: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 1 / 27

Slide 2 / 27

Page 1

Page 2: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 3 / 27

Slide 4 / 27

Page 2

Page 3: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 5 / 27

Slide 6 / 27

Page 3

Page 4: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 7 / 27

Slide 8 / 27

Page 4

Page 5: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 9 / 27

Slide 10 / 27

Page 5

Page 6: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 11 / 27

Slide 12 / 27

Page 6

Page 7: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 13 / 27

Slide 14 / 27

Page 7

Page 8: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 15 / 27

Slide 16 / 27

Page 8

Page 9: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 17 / 27

Slide 18 / 27

Page 9

Page 10: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 19 / 27

Slide 20 / 27

Page 10

Page 11: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 21 / 27

Slide 22 / 27

Page 11

Page 12: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 23 / 27

Slide 24 / 27

Page 12

Page 13: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 25 / 27

Slide 26 / 27

Page 13

Page 14: Slide 2 / 27 · Slide 1 / 27 Slide 2 / 27 Page 1. undefined S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG

undefined

S4-06 HER2 STATUS AS PREDICTIVE MARKER FOR AI VS TAM BENEFIT: A TRANS-AIOG META-ANALYSIS OF 12129 PATIENTS FROM ATAC, BIG 1-98 AND TEAM WITH CENTRALLY DETERMINED HER2Speaker: John MS Bartlett

Slide 27 / 27

Page 14